| Literature DB >> 18523243 |
Craig Meagher1, Qizhi Tang, Brian T Fife, Helene Bour-Jordan, Jenny Wu, Cecile Pardoux, Mingying Bi, Kristin Melli, Jeffrey A Bluestone.
Abstract
Autoimmune pancreatitis (AIP) is a heterogeneous autoimmune disease in humans characterized by a progressive lymphocytic and plasmacytic infiltrate in the exocrine pancreas. In this study, we report that regulatory T cell-deficient NOD.CD28KO mice spontaneously develop AIP that closely resembles the human disease. NOD mouse AIP was associated with severe periductal and parenchymal inflammation of the exocrine pancreas by CD4(+) T cells, CD8(+) T cells, and B cells. Spleen CD4(+) T cells were found to be both necessary and sufficient for the development of AIP. Autoantibodies and autoreactive T cells from affected mice recognized a approximately 50-kDa protein identified as pancreatic amylase. Importantly, administration of tolerogenic amylase-coupled fixed spleen cells significantly ameliorated disease severity, suggesting that this protein functions as a key autoantigen. The establishment and characterization of this spontaneous pancreatic amylase-specific AIP in regulatory T cell-deficient NOD.CD28KO mice provides an excellent model for the study of disease pathogenesis and development of new therapies for human autoimmune pancreatitis.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18523243 PMCID: PMC2429990 DOI: 10.4049/jimmunol.180.12.7793
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422